Clinical Trial Update: PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

View source ↗

Summary

A clinical trial in recruitment evaluating PAS 1ml Magtrace for sentinel lymph node biopsy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Magtrace

Snippet

Sponsor: Endomagnetics Ltd. | Conditions: Breast Cancer | Status: RECRUITING